FDAnews
www.fdanews.com/articles/138691-carbylan-biosurgery-announces-positive-clinical-trial-results-for-hydros-ta-in-patients-with-pain-from-knee-osteoarthritis

Carbylan BioSurgery Announces Positive Clinical Trial Results for Hydros-TA in Patients with Pain from Knee Osteoarthritis

July 26, 2011
Carbylan BioSurgery announced positive results in its double-blinded, multi-center clinical trial which evaluated the safety and effectiveness of Hydros-TA Joint Therapy and Hydros as compared to Synvisc-One in patients with osteoarthritis of the knee.
SYS-CON